Detection of Clostridium sordellii strains expressing hemorrhagic toxin (TcsH) and implications for diagnostics and regulation of veterinary vaccines

Vaccine

Volumn 31, Issue 44, 2013, Pages 5082-5087

  Thiele, Teri L ^a   Stuber, Tod P ^b   Hauer, Paul J ^b  

^a UNITED STATES DEPARTMENT OF AGRICULTURE   (United States)

^b National Veterinary Services Laboratories   (United States)

Author keywords

Clostridium sordellii; Hemorrhagic toxin; TcsH

Indexed keywords

BACTERIAL TOXIN; BACTERIAL VACCINE; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; CLOSTRIDIUM SORDELLII HEMORRHAGIC TOXIN; CLOSTRIDIUM SORDELLII LETHAL TOXIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; AMPLICON; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; CLOSTRIDIUM INFECTION; CLOSTRIDIUM SORDELLII; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SEQUENCE; GENOME ANALYSIS; GENOTYPE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; VETERINARY MEDICINE;

CLOSTRIDIUM SORDELLII; HEMORRHAGIC TOXIN; TCSH;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTITOXINS; BACTERIAL TOXINS; BACTERIAL VACCINES; CLOSTRIDIUM SORDELLII; DNA, BACTERIAL; ENTEROTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENES, BACTERIAL; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TOXICITY TESTS; UNITED STATES; VACCINATION; VIRULENCE;

EID: 84885425324     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.08.065     Document Type: Article

References (20)

1. Arseculeratne S.N., Panabokke R.G., Wijesundera S. The toxins responsible for the lesions of Clostridium sordelli gas gangrene. J Med Microbiol 1969, 2(1):37-53.
2. Aldape M.J., Bryant A.E., Stevens D.L. Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment. Clin Infect Dis 2006, 43(11):1436-1446.
3. Kimura A.C., Higa J.I., Levin R.M., Simpson G., Vargas Y., Vugia J.D. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clin Infect Dis 2004, 38(9):pe87-91.
4. Bangsberg D.R., Rosen J.I., Aragon T., Campbell A., Weir L., Perdreau-Remington F. Clostridial myonecrosis cluster among injection drug users: a molecular epidemiology investigation. Arch Intern Med 2002, 162(5):517-522.
5. Smith L.D. The pathogenic anaerobic bacteria 1975, Charles C. Thomas Publishing, Springfield, IL. 2nd ed.
6. Martinez R.D., Wilkins T.D. Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C. difficile. J Med Microbiol 1992, 36(1):30-36.
7. Schirmer J., Aktories K. Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins. Biochim Biophys Acta 2004, 1673(1-2):66-74.
8. Schwan C., Stecher B., Tzivelekidis T., van Ham M., Rohde M., Hardt W.D., et al. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog 2009, 5(10):pe1000626.
9. Hao Y., Senn T., Opp J.S., Young V.B., Thiele T., Srinivas G., et al. Lethal toxin is a critical determinant of rapid mortality in rodent models of Clostridium sordellii endometritis. Anaerobe 2010, 16(2):155-160.
10. USDA 9 code of federal regulations. Animal and animal products part 113.109 2011, Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register, Washington, DC, [Revised as of January 1, 2011 ed].
11. WHO International standard Clostridium sordellii (Gas-gangrene) antitoxin, equine, 1st International Standard 2013, Available from: http://www.nibsc.ac.uk/documents/ifu/09-154.pdf.
12. Martinez R.D., Wilkins T.D. Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin). Infect Immun 1988, 56(5):1215-1221.
13. United States Department of Agriculture, C.V.B., supplemental assay method for potency testing Clostridium sordellii antigen (SAM 212) 2010, [November 5].
14. Krivan H.C., Wilkins T.D. Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin. Infect Immun 1987, 55(8):1873-1877.
15. Stern N.J.a.G., Ray H. Hybridoma technology in agricultural and veterinary research 1984, Rowman & Allanheld, Totowa, NJ.
16. Wiggins C.A., Munro S. Activity of the yeast MNN1 alpha-1,3-mannosyltransferase requires a motif conserved in many other families of glycosyltransferases. Proc Natl Acad Sci U S A 1998, 95(14):7945-7950.
17. Busch C., Aktories K. Microbial toxins and the glycosylation of rho family GTPases. Curr Opin Struct Biol 2000, 10(5):528-535.
18. Carter G.P., Awad M.M., Hao Y., Thelen T., Bergin I.L., Howarth P.M., et al. TcsL is an essential virulence factor in Clostridium sordellii ATCC 9714. Infect Immun 2011, 79(3):1025-1032.
19. Amimoto K., Oishi E., Yasuhar H., Sasak O., Katayama S., Kitajima T., et al. Protective effects of Clostridium sordellii LT and HT toxoids against challenge with spores in guinea pigs. J Vet Med Sci 2001, 63(8):879-883.
20. USDA 9 code of federal regulations. Animal and animal products Part 113.94 1990, Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register, Washington, DC, [Revised as of January 1, 1990 ed].